Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Articles   |    
The Pharmacology of Tardive Dyskinesias
Am J Psychiatry 1973;130:82-86.
View Author and Article Information

Associate Attending Neurologist, Department of Neurological Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago, Ill. 60612

1973, The American Psychiatric Association

text A A A
PDF of the full text article.

The activity of dopamine at certain striatal dopamine receptors is related to the appearance of tardive dyskinesias in man. By analogy to Huntington's chorea and L-dopa-induced dyskinesias in parkinsonism, it appears that tardive dyskinesias are related to increased responsiveness of dopamine receptor sites as a result of neuroleptic-induced denervation hypersensitivity. It has been demonstrated that anticholinergic drugs worsen tardive dyskinesias in patients who have this disorder. It also appears that anticholinergic drugs decrease the threshold for tardive dyskinesias and thereby increase the incidence of this disorder. This implies that centrally active anticholinergic agents should not be used as a routine adjunct to neuroleptic therapy.

Abstract Teaser
Figures in this Article

Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Web of Science® Times Cited: 518

Related Content
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 56.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 9.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
Textbook of Traumatic Brain Injury, 2nd Edition > Chapter 20.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 49.  >
Topic Collections
Psychiatric News
PubMed Articles
Calming Alzheimer's agitation: a promising drug. Johns Hopkins Med Lett Health After 50 2014;29(5):8.